JLINX
Johnson & Johnson Innovative Medicine is dedicated to developing science-based innovations to change and save lives. Inspired by patients and the legacy of Dr. Paul Janssen, the company focuses on complex diseases, pioneering treatments, and unlocking potential medicines of tomorrow. It spans multiple therapeutic areas including Oncology, Immunology, Neuroscience, Cardiopulmonary, and Specialty Ophthalmology, and collaborates globally to bring health breakthroughs to market faster.
Industries
Nr. of Employees
medium (51-250)
Products
Portfolio of prescription medicines and vaccines
A portfolio of investigational and approved therapeutic and preventive products spanning oncology, immunology, neuroscience, cardiopulmonary diseases, specialty ophthalmology and communicable diseases.
Portfolio of prescription medicines and vaccines
A portfolio of investigational and approved therapeutic and preventive products spanning oncology, immunology, neuroscience, cardiopulmonary diseases, specialty ophthalmology and communicable diseases.
Services
Partnerships and external collaboration programs
Structured programs to form academic, industry and non-profit partnerships for discovery, clinical development and access initiatives.
Patient engagement and grants programs
Grant funding and engagement with patient organizations to support education, research and improved clinical trial participation.
Strategic investment and business development support
Identification, valuation and progression of external investment and partnership opportunities to advance innovation priorities.
Regulatory and market access planning
Regulatory engagement, submissions and market access strategy to support approvals, labeling and reimbursement across regions.
External innovation scouting and evaluation
Identification and assessment of external scientific and technological opportunities to inform prevention and early-development portfolios.
Partnerships and external collaboration programs
Structured programs to form academic, industry and non-profit partnerships for discovery, clinical development and access initiatives.
Patient engagement and grants programs
Grant funding and engagement with patient organizations to support education, research and improved clinical trial participation.
Strategic investment and business development support
Identification, valuation and progression of external investment and partnership opportunities to advance innovation priorities.
Regulatory and market access planning
Regulatory engagement, submissions and market access strategy to support approvals, labeling and reimbursement across regions.
External innovation scouting and evaluation
Identification and assessment of external scientific and technological opportunities to inform prevention and early-development portfolios.
Expertise Areas
- Clinical trial management
- Data science and AI for drug development
- Biomarker discovery and translational research
- Microbiome therapeutics
Key Technologies
- AI-driven analytics
- Digital health platforms
- Microbiome modulation approaches
- Biomarker assays and validation